| ADAM(TS) | a disintegrin and a metalloproteinase (with thrombospondin-1 motif) |
| BM | basement membrane |
| CAF | cancer-associated fibroblast |
| CAM | cell adhesion molecule |
| CCN | connective tissue growth factor (CTGF), cysteine-rich protein (Cyr61) and nephroblastoma overexpressed (NOV) |
| EC | endothelial cell |
| ECM | extracellular matrix |
| ED-A/B | extra domain-A/B |
| EGF(R) | epidermal growth factor (receptor) |
| EMT | epithelial–mesenchymal transition |
| GAG | glycosaminoglycan |
| GPI | glycosylphosphatidylinositol |
| HGF | hepatocyte growth factor |
| HIF | hypoxia-inducible factor |
| H/LMW-HA | high/low molecular weight hyaluronic acid |
| LOXL | lysyl oxidase-like |
| LPA1R | lysophosphatidic acid receptor 1 |
| (MT-)MMP | (membrane-type) matrix metalloproteinase |
| NOX | nicotinamide adenine dinucleotide phosphate (NADPH) oxidase |
| PAR | protease-activated receptor |
| RHAMM | receptor for hyaluronic acid-mediated migration |
| ROS | reactive oxygen species |
| SIBLING | small integrin-binding ligand N-linked glycoprotein |
| SLRP | small leucine-rich protein |
| SPARC | secreted protein acidic and rich in cysteine |
| TC | tumor cell |
| TGF-β | transforming growth factor- β |
| TIMP | tissue inhibitors of metalloproteinases |
| TLR | Toll-like receptor |
| TME | tumor microenvironment |
| VEGF | vascular endothelial cell growth factor |